IL298996A - Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof - Google Patents

Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof

Info

Publication number
IL298996A
IL298996A IL298996A IL29899622A IL298996A IL 298996 A IL298996 A IL 298996A IL 298996 A IL298996 A IL 298996A IL 29899622 A IL29899622 A IL 29899622A IL 298996 A IL298996 A IL 298996A
Authority
IL
Israel
Prior art keywords
fingolimod
sphingosine
derivatives
compositions
preventing
Prior art date
Application number
IL298996A
Other languages
Hebrew (he)
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of IL298996A publication Critical patent/IL298996A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL298996A 2020-06-11 2021-06-09 Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof IL298996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063037910P 2020-06-11 2020-06-11
PCT/US2021/036628 WO2021252636A1 (en) 2020-06-11 2021-06-09 Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof

Publications (1)

Publication Number Publication Date
IL298996A true IL298996A (en) 2023-02-01

Family

ID=78846511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL298996A IL298996A (en) 2020-06-11 2021-06-09 Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof

Country Status (7)

Country Link
EP (1) EP4164605A4 (en)
JP (1) JP2023530681A (en)
KR (1) KR20230051154A (en)
CN (1) CN116133665A (en)
CA (1) CA3182431A1 (en)
IL (1) IL298996A (en)
WO (1) WO2021252636A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
WO2015138700A1 (en) * 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US20210113529A1 (en) * 2018-02-02 2021-04-22 Kyoto University Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability

Also Published As

Publication number Publication date
KR20230051154A (en) 2023-04-17
EP4164605A1 (en) 2023-04-19
WO2021252636A1 (en) 2021-12-16
CA3182431A1 (en) 2021-12-16
JP2023530681A (en) 2023-07-19
EP4164605A4 (en) 2024-06-19
CN116133665A (en) 2023-05-16

Similar Documents

Publication Publication Date Title
MX2020003901A (en) Compositions and methods for modulating growth hormone receptor expression.
WO2007092190A3 (en) Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
EP4026536A4 (en) Cationic nanodrug, preparation method therefor, and drug-loaded implantable medical device
EP4051291A4 (en) Methods and compositions for treating a premature termination codon-mediated disorder
EP3887351A4 (en) Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
ZA201904387B (en) Compositions and methods for treating, ameliorating and preventing h. pylori
WO2015002971A3 (en) Modulators of growth hormone receptor
EP4034167A4 (en) Methods and compositions for treating a disease or disorder
MY194227A (en) Modulators of pcsk9 expression
WO2019147846A8 (en) Delivery system for aided replacement valve recapture and repositioning post- deployment
EP3998091A4 (en) Tissue engineering material for nerve injury repair, preparation method therefor and application thereof
IL298996A (en) Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof
EP3822226A4 (en) Packaged body containing hydrogen sulfide slow-release agent and method for producing same, and hydrogen sulfide slow-release agent, hydrogen sulfide slow-release body and hydrogen sulfide generation method using same
EP3760215A4 (en) Composition for preventing, alleviating, or treating cachexia and muscle loss
PT3851130T (en) Injection formulation containing poly-l-lactic acid filler and hyaluronic acid filler conjugate, and method for preparing same
IL286646A (en) Compositions, devices and methods for treating fabry disease
EP4138841A4 (en) A formulation for treating ophthalmic conditions
GB202110228D0 (en) Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
EP3835061A4 (en) Film for agricultural use, resin composition for forming film for agricultural use, and method for growing plant using same
EP3834822C0 (en) Polymer nanoparticle composition for delivering virus, and preparation method therefor
EP4267645A4 (en) A curing agent, a process for preparation and application thereof
EP4053340A4 (en) Artificial turf, filler for artificial turf, and artificial turf production method
EP3885379A4 (en) Modifying agent, modified conjugated diene-based polymer including same and method for preparing polymer
EP3950679A4 (en) Nitrone azine crystal form, preparation method and application
EP4023696A4 (en) Cationic curing agent, method for producing same and cationically curable composition